Press Releases

L-carnitine Market Size to Worth Around USD 280.5 Mn by 2030

Share This Article

The global L-carnitine market size is expected to reach USD 280.5 million by 2030 and is expected to expand at a CAGR of 7.1% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38667

Growth Factors

 Growing consumer awareness regarding product benefits, along with increasing demand from end-use industries such as pharmaceutical, nutraceutical, and animal feed, is projected to drive the market over the forecast period.

The market is witnessing a high growth owing to a rising health-conscious consumer base, increasing number of product launches consisting of L-carnitine, and increasing demand from the animal feed industry.

L-carnitine and its derivatives are used for numerous applications including male infertility, kidney treatment, cardiovascular diseases, weight reduction, and bone mass. It is also used in various products including animal feed, health supplements, functional drinks, medicines, and other nutraceutical products.

Report Coverage

Report Scope Details
Market Size USD 280.5 million by 2030,
Growth Rate CAGR of 7.1% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Process, Product, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Lonza; Northeast Pharmaceutical Group Co., Ltd. (NEPG); Biosint S.p.A.; Cayman Chemical; Merck KGaA; Tokyo Chemical Industry Co., Ltd.; Ceva; Kaiyuan Hengtai Nutrition Co., Ltd.; ChengDa PharmaCeuticals Co., Ltd.; Huanggang Huayang Pharmaceutical Co. Ltd.; HuBeiYuancheng SaichuangTechnology Co, .Ltd.

By Process Analysis

The bioprocess segment held the market and dominated for the highest revenue share of over 77.0% in 2020. Rising commercial demand for L-carnitine has compelled the manufacturers to improve their processes to upsurge production yield.

The most conventional process used to produce L-carnitine with the best yield is a bioprocess based on achiral precursors’ biotransformation such as γ-butyrobetaine, crotonobetaine, and 3-dehydrocarnitine, or racemic mixtures such as D, L-carnitinamide, D, L-acyl carnitine, and D, L-carnitine.

The chemical synthesis process is slowly gaining momentum owing to its ability to produce L-carnitine on an industrial scale. There are several chemical procedures available for the synthesis of L-carnitine namely asymmetric synthesis, chemical multi-step racemization, enzymatic techniques, resolution through diastereomeric derivatives, and synthesis using chiral materials.

By Product Analysis

The food and pharmaceutical grade segment held the market and dominated for the highest revenue share of more than 79.0% in 2020. Food and pharmaceutical grade L-carnitine is primarily used for human consumption for numerous applications including healthy aging, male fertility, infant nutrition, weight management, and post-exercise recovery.

Though the product is found naturally in certain foods including meat, avocado, and beans, a certain level of L-carnitine is needed to maintain its adequate level in the body depending upon age, diet, and other factors. The product is consumed through various routes including oral consumption through nutritional supplements, medicines, functional food and beverages, and injections.

By Application Analysis

The healthcare products dominated the market and dominated for the highest revenue share of more than 35.0% in 2020. L-carnitine is widely used in numerous healthcare products including supplements for weight loss and enhanced stamina.

With the growing consumption of dietary supplements due to the rising prevalence of obesity, increasing consumer awareness regarding personal health and wellbeing, changing lifestyle, and growing spending capacity, the dietary supplement market is expected to reach USD 272.4 billion by 2028.

Supplementation of L-carnitine in the diet of animals significantly improves their body weight gain, feed intake, and feed conversion in broiler chicken. Supplementation of L-carnitine in feed improves energy utilization and fatty acid and therefore, live weight gain and feed conversion efficiency may be improved in poultry.

By Regional Analysis

 North America dominated the L-carnitine market and accounted for the largest revenue share of over 38.0% in 2020. Over the past decade, the functional food and beverages industry has seen a huge growth in North America with the expansion of a health-conscious consumer base in the region.

L-carnitine has proved to be an essential component for the treatment and prevention of various ailments, which has made it an attractive functional food and beverage ingredient. The increased level of energy and stamina including other health benefits has made consumers more biased toward functional food and beverages inclusive of L-carnitine.

The nutraceutical industry in Europe is expected to grow due to an increase in the purchase of supplements as a preventive approach to health concerns. In addition, consumers prefer herbal products over pharmaceuticals due to the latter’s side effects.

Key Players

  • Lonza
  • Northeast Pharmaceutical Group Co., Ltd. (NEPG)
  • Biosint S.p.A.
  • Cayman Chemical
  • Merck KGaA
  • Tokyo Chemical Industry Co., Ltd.
  • Ceva
  • Kaiyuan Hengtai Nutrition Co., Ltd.
  • ChengDa PharmaCeuticals Co., Ltd.
  • Huanggang Huayang Pharmaceutical Co. Ltd.
  • HuBeiYuancheng SaichuangTechnology Co, .Ltd.

Market Segmentation

  • Process
    • Chemical Synthesis
    • Bioprocess
  • Product
    • Food & Pharma Grade
    • Feed Grade
  • Application
    • Animal Feed
    • Healthcare Products
    • Functional Food & Beverages
    • Medicines
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
    • Central & South America
      • Brazil
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38667

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global L-carnitine Market, By Process

7.1.  L-carnitine Market, by Process, 2021-2030

7.1.1.    Chemical Synthesis

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Bioprocess

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global L-carnitine Market, By Product

8.1.  L-carnitine Market, by Product, 2021-2030

8.1.1.    Food & Pharma Grade

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Feed Grade

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global L-carnitine Market, By Application

9.1.  L-carnitine Market, by Application, 2021-2030

9.1.1.    Animal Feed

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Healthcare Products

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Functional Food & Beverages

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Medicines

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global L-carnitine Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Process (2017-2030)

10.1.2.  Market Revenue and Forecast, by Product (2017-2030)

10.1.3.  Market Revenue and Forecast, by Application (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Process (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Process (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Process (2017-2030)

10.2.2.  Market Revenue and Forecast, by Product (2017-2030)

10.2.3.  Market Revenue and Forecast, by Application (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Process (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Process (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Process (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Process (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Process (2017-2030)

10.3.2.  Market Revenue and Forecast, by Product (2017-2030)

10.3.3.  Market Revenue and Forecast, by Application (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Process (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Process (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Process (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Process (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Process (2017-2030)

10.4.2.  Market Revenue and Forecast, by Product (2017-2030)

10.4.3.  Market Revenue and Forecast, by Application (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Process (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Process (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Process (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Process (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Process (2017-2030)

10.5.2.  Market Revenue and Forecast, by Product (2017-2030)

10.5.3.  Market Revenue and Forecast, by Application (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Process (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Process (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

Chapter 11.  Company Profiles

11.1.              Lonza

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Northeast Pharmaceutical Group Co., Ltd. (NEPG)

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Biosint S.p.A.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Cayman Chemical

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Merck KGaA

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Tokyo Chemical Industry Co., Ltd.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Ceva

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Kaiyuan Hengtai Nutrition Co., Ltd.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              ChengDa PharmaCeuticals Co., Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Huanggang Huayang Pharmaceutical Co. Ltd.

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38667

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button